Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Weill Cornell Medicine Courses and Meetings
Avatar

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors and PD-1 and CTLA-4 Combination Immunotherapy

By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
By Weill Cornell Medicine Courses and Meetings FEATURING Paul Chapman
89 views
June 10, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Brain
08:11

Leptomeningeal Metastases: Definitions, Localization, Presentation, …

Weill Cornell Medicine Courses and Meetings

A. Boire

406 views
12:58

Leptomeningeal Metastases: Intrathecal/Systemic Treatments and Front…

Weill Cornell Medicine Courses and Meetings

A. Boire

681 views
14:10

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Weill Cornell Medicine Courses and Meetings

P. Chapman

89 views